These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Relatively good safety in Swedish phase I trials. A survey of studies reported to the Medical Products Agency during 3 years]. Glazer A; Hedenmalm K Lakartidningen; 2008 Sep 10-16; 105(37):2482-4. PubMed ID: 19006863 [No Abstract] [Full Text] [Related]
5. Use of monoclonal antibodies and liposomes to improve drug delivery. Present status and future implications. Gregoriadis G Drugs; 1982 Oct; 24(4):261-6. PubMed ID: 7140578 [No Abstract] [Full Text] [Related]
6. Monoclonal antibodies to drugs: novel diagnostic and therapeutic reagents. Zalcberg JR Pharmacol Ther; 1985; 28(3):273-85. PubMed ID: 3911217 [No Abstract] [Full Text] [Related]
7. Billion dollar babies--biotech drugs as blockbusters. Lawrence S Nat Biotechnol; 2007 Apr; 25(4):380-2. PubMed ID: 17420735 [No Abstract] [Full Text] [Related]
8. [Monoclonal antibodies and therapeutics]. Desgranges C Pathol Biol (Paris); 2004 Jul; 52(6):351-64. PubMed ID: 15261379 [TBL] [Abstract][Full Text] [Related]
9. Testing new drugs in naked apes and getting the dose right in their young. Ritter JM Br J Clin Pharmacol; 2010 Oct; 70(4):467-70. PubMed ID: 20840438 [No Abstract] [Full Text] [Related]
10. Monoclonal antibodies in the treatment of indolent lymphomas. Coiffier B Best Pract Res Clin Haematol; 2005 Mar; 18(1):69-80. PubMed ID: 15694185 [TBL] [Abstract][Full Text] [Related]
11. Drug targeting via retrometabolic approaches. Bodor N; Buchwald P Pharmacol Ther; 1997; 76(1-3):1-27. PubMed ID: 9535166 [TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical approaches to colon targeted drug delivery systems. Chourasia MK; Jain SK J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729 [TBL] [Abstract][Full Text] [Related]
14. Failure of monoclonal antibodies against tumor associated antigens to improve tumor targeting of LAK cells in a model of rat colon carcinoma. Zennadi R; Blottière MH; Burg C; Le Pendu J; Douillard JY Bull Cancer; 1993 Aug; 80(8):674-9. PubMed ID: 8204947 [TBL] [Abstract][Full Text] [Related]
15. Engineered affinity proteins for tumour-targeting applications. Friedman M; Ståhl S Biotechnol Appl Biochem; 2009 May; 53(Pt 1):1-29. PubMed ID: 19341363 [TBL] [Abstract][Full Text] [Related]
16. Selective delivery of drugs encapsulated in liposomes: natural targeting to macrophages involved in various disease states. Schroit AJ; Hart IR; Madsen J; Fidler IJ J Biol Response Mod; 1983; 2(2):97-100. PubMed ID: 6644336 [TBL] [Abstract][Full Text] [Related]
17. Cationization of monoclonal antibodies: another step towards the "magic bullet"? Vaisitti T; Deaglio S; Malavasi F J Biol Regul Homeost Agents; 2005; 19(3-4):105-12. PubMed ID: 16602624 [TBL] [Abstract][Full Text] [Related]